BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33489441)

  • 1. Outcomes of adult critically ill patients with hemophagocytic lymphohistiocytosis in united states-analysis from an administrative database from 2007 to 2015.
    Kumar G; Hererra M; Patel D; Nanchal R; Guddati AK
    Am J Blood Res; 2020; 10(6):330-338. PubMed ID: 33489441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and mortality of hemophagocytic lymphohistiocytosis in critically ill children: A systematic review and meta-analysis.
    Tan CJ; Ng ZQ; Bhattacharyya R; Sultana R; Lee JH
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30122. PubMed ID: 36579732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Diagnosis of Hyperferritinemia in Critically Ill Patients.
    Schuster FS; Nyvlt P; Heeren P; Spies C; Adam MF; Schenk T; Brunkhorst FM; Janka G; La Rosée P; Lachmann C; Lachmann G
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
    Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Profile, Treatment, and Outcome of Patients with Secondary Hemophagocytic Lymphohistiocytosis in Critically Ill Patients: A Prospective Observational Study.
    Fazal F; Gupta N; Soneja M; Mitra DK; Satpathy G; Panda SK; Chaturvedi PK; Vikram NK; Pandey RM; Wig N
    Indian J Crit Care Med; 2022 May; 26(5):564-567. PubMed ID: 35719456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
    Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critically Ill Children With Hemophagocytic Lymphohistiocytosis: A Case Series of 14 Patients.
    Leow EH; Soh SY; Tan AM; Mok YH; Chan MY; Lee JH
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):e303-e306. PubMed ID: 28697170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemophagocytic lymphohistiocytosis in critically ill patients].
    Eichenauer DA; Lachmann G; La Rosée P
    Med Klin Intensivmed Notfmed; 2021 Mar; 116(2):129-134. PubMed ID: 33580314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis.
    Valade S; Azoulay E; Galicier L; Boutboul D; Zafrani L; Stepanian A; Canet E; Lemiale V; Venot M; Veyradier A; Mariotte E
    Medicine (Baltimore); 2015 Oct; 94(40):e1692. PubMed ID: 26448017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
    Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
    J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Hemophagocytic Lymphohistiocytosis in a Young Hispanic Adult.
    Flores Chang BS; Arias Morales CE; Flores Chang MM; Vigoda I
    Cureus; 2021 Feb; 13(2):e13084. PubMed ID: 33680624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemophagocytic lymphohistiocytosis in critically ill patients].
    Eichenauer DA; Lachmann G; La Rosée P
    Wien Klin Mag; 2021; 24(6):246-251. PubMed ID: 34697559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the critically ill child with the sepsis/hemophagocytic lymphohistiocytosis/macrophage activation syndrome overlap syndrome.
    Demirkol D; Carcillo J
    J Pediatr Intensive Care; 2014 Dec; 3(4):243-254. PubMed ID: 31214471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Hemophagocytic Lymphohistiocytosis Who Need Intensive Care Can Be Successfully Rescued by Timely Using Etoposide-Based HLH Regimens.
    Lv K; Cheng X; Zhou Y; Yu M; Wang S; Shen H; Li F
    Int J Gen Med; 2024; 17():431-446. PubMed ID: 38333019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Performance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
    Meena NK; Sinokrot O; Duggal A; Alpat D; Singh ZN; Coviello JM; Li M; Wang X; Mireles-Cabodevila E
    J Intensive Care Med; 2020 Dec; 35(12):1476-1482. PubMed ID: 30862243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Interleukin-2 Receptor Level as a Marker of Hemophagocytic Lymphohistiocytosis in Children With Severe Dengue.
    Singh D; Raghunathan V; Dhaliwal M; Rastogi N; Chadha R; Yadav SP
    Front Pediatr; 2021; 9():721857. PubMed ID: 34778128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and Mortality of Hemophagocytic Lymphohistiocytosis in Adult Critically Ill Patients: A Systematic Review With Pooled Analysis.
    Knaak C; Schuster FS; Nyvlt P; Spies C; Feinkohl I; Beutel G; Schenk T; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care Med; 2020 Nov; 48(11):e1137-e1146. PubMed ID: 32947471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Outcomes of Neonatal Hemophagocytic Lymphohistiocytosis.
    Balakumar N; Sendi P; Totapally BR
    Front Pediatr; 2022; 10():848004. PubMed ID: 35558361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Lymphoma-Associated Hemophagocytic Syndrome in a Young Woman.
    Ali K; Medina J; Benedetto PW
    Cureus; 2024 Feb; 16(2):e53649. PubMed ID: 38449949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.